JP2009517480A5 - - Google Patents

Download PDF

Info

Publication number
JP2009517480A5
JP2009517480A5 JP2008543418A JP2008543418A JP2009517480A5 JP 2009517480 A5 JP2009517480 A5 JP 2009517480A5 JP 2008543418 A JP2008543418 A JP 2008543418A JP 2008543418 A JP2008543418 A JP 2008543418A JP 2009517480 A5 JP2009517480 A5 JP 2009517480A5
Authority
JP
Japan
Prior art keywords
compound
enantiomer
group
compounds
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008543418A
Other languages
English (en)
Japanese (ja)
Other versions
JP5302005B2 (ja
JP2009517480A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/045673 external-priority patent/WO2007064697A1/en
Publication of JP2009517480A publication Critical patent/JP2009517480A/ja
Publication of JP2009517480A5 publication Critical patent/JP2009517480A5/ja
Application granted granted Critical
Publication of JP5302005B2 publication Critical patent/JP5302005B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008543418A 2005-12-01 2006-11-30 セロトニン作動性および／またはノルエピネフリン作動性の活性を有する置換フェネチルアミン Expired - Fee Related JP5302005B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US74131505P 2005-12-01 2005-12-01
US60/741,315 2005-12-01
US84136606P 2006-08-30 2006-08-30
US60/841,366 2006-08-30
PCT/US2006/045673 WO2007064697A1 (en) 2005-12-01 2006-11-30 Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity

Publications (3)

Publication Number Publication Date
JP2009517480A JP2009517480A (ja) 2009-04-30
JP2009517480A5 true JP2009517480A5 (https=) 2013-01-17
JP5302005B2 JP5302005B2 (ja) 2013-10-02

Family

ID=37776574

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008543418A Expired - Fee Related JP5302005B2 (ja) 2005-12-01 2006-11-30 セロトニン作動性および／またはノルエピネフリン作動性の活性を有する置換フェネチルアミン

Country Status (18)

Country Link
US (9) US7456317B2 (https=)
EP (2) EP1954669B1 (https=)
JP (1) JP5302005B2 (https=)
KR (1) KR101068180B1 (https=)
AU (1) AU2006320655A1 (https=)
BR (1) BRPI0620587A2 (https=)
CA (1) CA2631581C (https=)
DK (1) DK1954669T3 (https=)
EA (1) EA200801488A1 (https=)
ES (1) ES2549079T3 (https=)
HU (1) HUE027865T2 (https=)
IL (1) IL191847A0 (https=)
MA (1) MA30088B1 (https=)
NZ (1) NZ568720A (https=)
PL (1) PL1954669T3 (https=)
PT (1) PT1954669E (https=)
SI (1) SI1954669T1 (https=)
WO (1) WO2007064697A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100076087A1 (en) * 2005-10-06 2010-03-25 Auspex Pharmaceuticals, Inc. Methods of reduction of interpatient variability
PT1954669E (pt) * 2005-12-01 2015-10-23 Auspex Pharmaceuticals Inc Feniletilaminas substituídas com actividade serotoninérgica e/ou norepinefrinérgica
KR101338343B1 (ko) * 2006-08-31 2013-12-06 신닛테츠 수미킨 가가쿠 가부시키가이샤 유기 전계발광 소자 재료 및 유기 전계발광 소자
SI2125698T1 (sl) 2007-03-15 2016-12-30 Auspex Pharmaceuticals, Inc. Devterirani d9-venlafaksin
WO2009032843A2 (en) * 2007-09-06 2009-03-12 Auspex Pharmaceuticals, Inc. Deuterated ethambutols and their use
US20110053968A1 (en) * 2009-06-09 2011-03-03 Auspex Pharmaceuticals, Inc. Aminopyrimidine inhibitors of tyrosine kinase
US8586760B2 (en) * 2009-06-15 2013-11-19 Auspex Pharmaceuticals, Inc. Aminothiazole modulators of beta-3-adrenoreceptor
US20120301463A1 (en) 2009-09-30 2012-11-29 President And Fellows Of Harvard College Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products
DK2720989T3 (en) 2011-06-20 2016-11-28 H Lundbeck As Deuterated 1-piperazino-3-phenyl-indanes used to treat schizophrenia
KR20160117596A (ko) 2014-02-07 2016-10-10 오스펙스 파마슈티칼스, 인코포레이티드 신규 제약 제제
CN104059030B (zh) 2014-05-30 2016-05-04 镇江圣安医药有限公司 [(苯硫烷基)-苯基]哌嗪的衍生物及其药物组合物和用途
WO2017079102A1 (en) * 2015-11-03 2017-05-11 Albert Einstein College Of Medicine, Inc. Use of 13c derivatization reagents for gas or liquid chromatography-mass spectroscopy chemical identification and quantification
WO2020114853A1 (en) 2018-12-03 2020-06-11 H. Lundbeck A/S Prodrugs of 4-((1r,3s)-6-chloro-3-phenyl-2,3-dihydro-1h-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1/r,3s)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1h-inden-1-yl)-2,2-dimethy-1-(methyl-d3)piperazine
US12240813B2 (en) 2020-05-19 2025-03-04 Cybin Irl Limited Deuterated tryptamine derivatives and methods of use
CN120917022A (zh) 2023-03-23 2025-11-07 葛兰素史密斯克莱知识产权(第3号)有限公司 氘代p2x3调节剂

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069346A (en) 1977-02-14 1978-01-17 The Dow Chemical Company Compositions and methods for anesthetizing an animal using deuterated analogues of halothane and chloroform
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
IE56324B1 (en) 1982-12-13 1991-06-19 American Home Prod Phenethylamine derivatives and intermediates therefor
SE9002043D0 (sv) 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
DE69429895T2 (de) 1993-06-28 2002-08-29 American Home Products Corp., Madison Neue Behandlungsmethoden durch Verwendung von Phenethylderivaten
TW344661B (en) 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
ES2293638T3 (es) 1994-03-25 2008-03-16 Isotechnika, Inc. Mejora de la eficacia de farmacos por deuteracion.
US6221335B1 (en) 1994-03-25 2001-04-24 Isotechnika, Inc. Method of using deuterated calcium channel blockers
US6334997B1 (en) * 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
US20030215507A1 (en) * 1996-03-25 2003-11-20 Wyeth Extended release formulation
US6274171B1 (en) * 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
US6884429B2 (en) * 1997-09-05 2005-04-26 Isotechnika International Inc. Medical devices incorporating deuterated rapamycin for controlled delivery thereof
US6342507B1 (en) 1997-09-05 2002-01-29 Isotechnika, Inc. Deuterated rapamycin compounds, method and uses thereof
AU750245B2 (en) 1997-10-08 2002-07-11 Aurinia Phamaceuticals Inc. Deuterated cyclosporine analogs and their use as immunomodulating agents
US6579899B1 (en) 1998-07-16 2003-06-17 Massachusetts Institute Of Technology Composition for treatment of stress
US6333342B1 (en) 1998-11-04 2001-12-25 Isotechnika, Inc Methods of pharmacological treatment using S(−) amlodipine
US6197828B1 (en) * 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
US6440710B1 (en) 1998-12-10 2002-08-27 The Scripps Research Institute Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds
US6071918A (en) * 1999-07-21 2000-06-06 Dupont Pharmaceuticals Company Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence
BR0013017A (pt) * 1999-08-13 2002-04-16 Vela Pharmaceuticals Inc Usos de composições para o tratamento ou prevenção dos distúrbios do sono usando doses muito baixas de ciclobenzaprina
US20050233459A1 (en) * 2003-11-26 2005-10-20 Melker Richard J Marker detection method and apparatus to monitor drug compliance
PT1104760E (pt) * 1999-12-03 2003-06-30 Pfizer Prod Inc Compostos de sulfamoil-heteroarilpirazole como agentes analgesicos e anti-inflamatorios
EP1134290A3 (en) * 2000-03-14 2004-01-02 Pfizer Products Inc. Pharmacophore models for the identification of the CYP2D6 inhibitory potency of selective serotonin reuptake inhibitors
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
US20050054942A1 (en) * 2002-01-22 2005-03-10 Melker Richard J. System and method for therapeutic drug monitoring
AU2002250058B2 (en) * 2001-02-12 2007-08-16 Wyeth Llc Novel succinate salt of O-desmethyl-venlafaxine
WO2002085297A2 (en) 2001-04-24 2002-10-31 East Carolina University Compositions & formulations with a non-glucocorticoid steroid &/or a ubiquinone & kit for treatment of respiratory & lung disease
IL146462A (en) * 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
TW200413273A (en) 2002-11-15 2004-08-01 Wako Pure Chem Ind Ltd Heavy hydrogenation method of heterocyclic rings
KR20060121178A (ko) 2003-12-12 2006-11-28 일라이 릴리 앤드 캄파니 일과성 전신 열감, 충동 조절 장애 및 일반적인 의학상태로 인한 인격 변화 치료용 선택적 노르에피네프린재흡수 억제제
US20050181071A1 (en) * 2004-02-18 2005-08-18 Binder Michael R. Method for the treatment of clinical depression
JP5036532B2 (ja) * 2004-04-08 2012-09-26 アルメテオン、インコーポレイテッド 血液凝固疾患治療のための物質およびその方法
US20050261278A1 (en) 2004-05-21 2005-11-24 Weiner David M Selective serotonin receptor inverse agonists as therapeutics for disease
JP2008514612A (ja) 2004-09-23 2008-05-08 ミシャロウ、アレクサンダー 対抗適応を誘発することにより神経伝達物質系を調節する方法
EP1812010A2 (en) 2004-10-18 2007-08-01 BTG International Limited Use of na+/ k+-atpase inhibitors and antagonists thereof
US20080033011A1 (en) * 2005-07-29 2008-02-07 Concert Pharmaceuticals Inc. Novel benzo[d][1,3]-dioxol derivatives
US20100076087A1 (en) 2005-10-06 2010-03-25 Auspex Pharmaceuticals, Inc. Methods of reduction of interpatient variability
US20080287774A1 (en) 2005-11-06 2008-11-20 Rachel Katz-Brull Magnetic Resonance Imaging and Spectroscopy Means and Methods Thereof
PT1954669E (pt) * 2005-12-01 2015-10-23 Auspex Pharmaceuticals Inc Feniletilaminas substituídas com actividade serotoninérgica e/ou norepinefrinérgica
US7750168B2 (en) 2006-02-10 2010-07-06 Sigma-Aldrich Co. Stabilized deuteroborane-tetrahydrofuran complex
US20090312435A1 (en) 2006-08-30 2009-12-17 Auspex Pharmaceuticals, Inc Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
SI2125698T1 (sl) * 2007-03-15 2016-12-30 Auspex Pharmaceuticals, Inc. Devterirani d9-venlafaksin
US20080280991A1 (en) 2007-05-08 2008-11-13 Auspex Pharmaceuticals, Inc. Substituted naphthalenes
US20090028873A1 (en) 2007-07-27 2009-01-29 Auspex Pharmaceuticals, Inc. Substituted cyclohexanols
US20090069431A1 (en) 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched milnacipran
US20090076162A1 (en) 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched desvenlafaxine
US20100007087A1 (en) * 2008-07-09 2010-01-14 John Michael Pryke Six fold game board and method of folding game board
WO2010028130A2 (en) 2008-09-03 2010-03-11 Concert Pharmaceuticals, Inc. Antidepressant compounds

Similar Documents

Publication Publication Date Title
US8138226B2 (en) Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
US20110130424A1 (en) Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
JP2009517480A5 (https=)
US20110136914A1 (en) Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity
US20090312435A1 (en) Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
CN101336226B (zh) 具有5-羟色胺能活性和/或去甲肾上腺素能活性的取代的苯乙胺
US20100137244A1 (en) Preparation and utility of hmg-coa reductase inhibitors
HK1216635A1 (en) Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
CN101360698A (zh) 具有血清素源性活性和/或去甲肾上腺素能活性的取代芳氧基丙胺
HK1126751A (en) Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity
HK1125626B (en) Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
HK1126774A (en) Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties